Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 3/20 | 0.44 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.44 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.44 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | PRUNE1 | Q86TP1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27033740 | 0.83 | NPC1 (0.57) | CDK1CCNB2CCNB1CCNB3APP | |
| SCHEMBL27089188 | 0.80 | CCNE2 (0.45) | CDK1CCNB2CCNB1CCNB3NPC1 | |
| SCHEMBL27089192 | 0.80 | CCNE2 (0.45) | CDK1CCNB2CCNB1CCNB3NPC1 | |
| SCHEMBL29998917 | 0.80 | CCNE2 (0.45) | CDK1CCNB2CCNB1CCNB3NPC1 | |
| SCHEMBL32669313 | 0.76 | CDK1 (0.51) | CDK1CCNB2CCNB1CCNB3APP | |
| SCHEMBL32669370 | 0.74 | PDE5A (0.51) | APPNPC1EGFRPOLBNR2F2 | |
| SCHEMBL29998943 | 0.71 | NPC1 (0.47) | CDK1CCNB2CCNB1CCNB3APP | |
| SCHEMBL27088883 | 0.71 | NPC1 (0.47) | CDK1CCNB2CCNB1CCNB3APP | |
| SCHEMBL16290847 | 0.70 | NPC1 (0.58) | NPC1EGFRPOLBNR2F2MAPT | |
| SCHEMBL29889719 | 0.70 | NPC1 (0.58) | NPC1EGFRPOLBNR2F2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034126-A1 | KRAS INHIBITORS | INCYTE CORP (US) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034126-A1 | KRAS INHIBITORS | KRAS, NRAS, HRAS | CDK1 625/4885CCNB2 588/4885CCNB1 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.